Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of Humacyte Human Acellular Vessel for traumatic vascular repair or reconstruction
MOH_2021-11-24_009940Phase 2Active, not recruiting
- Sponsor
- Humacyte
- Start
- Sep 2021
- Modality
- Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label trial of acellular tissue engineered vessel in vascular injury (2 cohorts), sponsored by Humacyte. Started Sep 2021; status: active, not recruiting.
02
Drugs
acellular tissue engineered vessel
03
Conditions
vascular injury
Beyond the preview
Go deeper on MOH_2021-11-24_009940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-11-24_009940.